Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children
Authors:
- 31 January 2024
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (6) , 487-492
Abstract
Background: Respiratory syncytial virus (RSV) is a common cause of bronchiolitis and pneumonia in infants and young children. Starting in December 2010, RSV monoclonal antibody (RSV mAb) was endorsed by Taiwan National Health Insurance and given to children with prematurity and/or congenital heart diseases, which are considered high-risk factors for severe RSV diseases. Investigating other important contributing risk factors is warranted. Methods: We conducted a cohort study at National Taiwan University Hospital to determine the rate of severe outcomes among children hospitalized due to RSV infection from 2008 to 2018. Adjusted for age, sex and birth cohorts born before and after RSV mAb endorsement, we identified risk factors for severe RSV infection, defined as the requirement of invasive ventilator support. Results: There were 1985 admissions due to RSV infections. Among them, 66 patients (3.3%) had severe RSV infection. The proportion of severe RSV infections decreased significantly after RSV mAb endorsement. Multivariable analysis revealed that age <1.5 months and cardiovascular and congenital/genetic diseases were high-risk underlying conditions. In addition, bacterial coinfections, elevated creatinine levels and initial abnormal chest radiograph findings posed warning signs for severe RSV infection. Conclusions: Children younger than 1.5 months of age with cardiovascular or congenital/genetic diseases were predisposed to severe RSV infection and might benefit from RSV mAb prophylaxis.Keywords
This publication has 24 references indexed in Scilit:
- Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2019
- Immune Dysfunction and Risk of Infection in Chronic Kidney DiseaseAdvances in Chronic Kidney Disease, 2019
- Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter StudyThe Journal of Pediatrics, 2018
- Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal InjuryFrontiers in Cellular and Infection Microbiology, 2016
- A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in TaiwanPLOS ONE, 2014
- Overview of Urea and CreatinineLaboratory Medicine, 2014
- Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000sInternational Journal of Antimicrobial Agents, 2011
- Epidemiological Study of Hospitalization Associated With Respiratory Syncytial Virus Infection in Taiwanese Children Between 2004 and 2007Journal of the Formosan Medical Association, 2011
- The histopathology of fatal untreated human respiratory syncytial virus infectionLaboratory Investigation, 2007
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000